The Role of Anti-Inflammatory Cytokines in Patients With Kidney Nephrosclerosis in Chronic Pyelonephritis

dc.creatorU. P, Shukurova
dc.creatorA. A, Khodzhimetov
dc.creatorN. Kh, Mukhamedova
dc.date2022-12-06
dc.date.accessioned2023-09-16T00:37:33Z
dc.date.available2023-09-16T00:37:33Z
dc.descriptionIn recent years, the pathogenetic mechanisms of the formation of nephrosclerosis have been actively studied, since nephrosclerosis is formed in 30-60% of patients with impaired urodynamics. At the same time, the participation of many factors in the progression of kidney damage in nephrosclerosis has been proven.en-US
dc.formatapplication/pdf
dc.identifierhttps://cejsr.academicjournal.io/index.php/journal/article/view/1617
dc.identifier.urihttps://dspace.umsida.ac.id/handle/123456789/35543
dc.languageeng
dc.publisherPublishing House Education and Science s.r.o.en-US
dc.relationhttps://cejsr.academicjournal.io/index.php/journal/article/view/1617/1510
dc.rightshttps://creativecommons.org/licenses/by/4.0en-US
dc.sourceStředoevropský vědecký bulletin; Vol 31 (2022): December; 1-3cs-CZ
dc.sourceMiddle European Scientific Bulletin; Vol. 31 (2022): December; 1-3en-US
dc.source2694-9970
dc.source10.47494/mesb.2022.31
dc.subjectAnti-Inflammatoryen-US
dc.subjectPyelonephritisen-US
dc.titleThe Role of Anti-Inflammatory Cytokines in Patients With Kidney Nephrosclerosis in Chronic Pyelonephritisen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
Files